These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32824820)

  • 1. MiRNA let-7 from TPO(+) Extracellular Vesicles is a Potential Marker for a Differential Diagnosis of Follicular Thyroid Nodules.
    Zabegina L; Nazarova I; Knyazeva M; Nikiforova N; Slyusarenko M; Titov S; Vasilyev D; Sleptsov I; Malek A
    Cells; 2020 Aug; 9(8):. PubMed ID: 32824820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.
    de Micco C; Savchenko V; Giorgi R; Sebag F; Henry JF
    Br J Cancer; 2008 Feb; 98(4):818-23. PubMed ID: 18212751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation markers differentiate thyroid cancer from benign nodules.
    Stephen JK; Chen KM; Merritt J; Chitale D; Divine G; Worsham MJ
    J Endocrinol Invest; 2018 Feb; 41(2):163-170. PubMed ID: 28612287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of thyroid specific peroxidase and Ki-67 stains in preoperative cytology for thyroid follicular tumors.
    Maruta J; Hashimoto H; Yamashita H; Noguchi H; Noguchi S; Kobayashi TK; Tsuneoka H; Takahashi M
    Diagn Cytopathol; 2015 Mar; 43(3):202-9. PubMed ID: 25195571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.
    Zhang H; Zhang Z; Liu X; Duan H; Xiang T; He Q; Su Z; Wu H; Liang Z
    J Clin Endocrinol Metab; 2021 Mar; 106(4):1011-1021. PubMed ID: 33394038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative serum thyroglobulin and changes in serum thyroglobulin during TSH suppression independently predict follicular thyroid carcinoma in thyroid nodules with a cytological diagnosis of follicular lesion.
    Kim HJ; Mok JO; Kim CH; Kim YJ; Kim SJ; Park HK; Byun DW; Suh K; Yoo MH
    Endocr Res; 2017 May; 42(2):154-162. PubMed ID: 27936964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
    Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
    BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CHEK1, SLC26A4, c-KIT, TPO and TG as new biomarkers for human follicular thyroid carcinoma.
    Makhlouf AM; Chitikova Z; Pusztaszeri M; Berczy M; Delucinge-Vivier C; Triponez F; Meyer P; Philippe J; Dibner C
    Oncotarget; 2016 Jul; 7(29):45776-45788. PubMed ID: 27329729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-step RT-qPCR for detection of extracellular vesicle microRNAs in vivo: a time- and cost-effective method.
    Lee H; He X; Le T; Carnino JM; Jin Y
    Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L742-L749. PubMed ID: 32073880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule.
    Christensen L; Blichert-Toft M; Brandt M; Lange M; Sneppen SB; Ravnsbaek J; Mollerup CL; Strange L; Jensen F; Kirkegaard J; Sand Hansen H; Sørensen SS; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):161-9. PubMed ID: 10931096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of follicular carcinomas from adenomas using histogram obtained from diffusion-weighted MRI.
    Chung SR; Lee JH; Yoon RK; Sung TY; Song DE; Pfeuffer J; Kim IS
    Clin Radiol; 2020 Nov; 75(11):878.e13-878.e19. PubMed ID: 32838926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal Dysregulation of MiR-146b and MiR-451 Contributes in Malignant Phenotype of Follicular Thyroid Tumor.
    Knyazeva M; Korobkina E; Karizky A; Sorokin M; Buzdin A; Vorobyev S; Malek A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer.
    Delcorte O; Craps J; Mahibullah S; Spourquet C; D'Auria L; Van Der Smissen P; Dessy C; Marbaix E; Mourad M; Pierreux CE
    Endocr Relat Cancer; 2022 May; 29(7):389-401. PubMed ID: 35521768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
    Teshima M; Tokita K; Ryo E; Matsumoto F; Kondo M; Ikegami Y; Shinomiya H; Otsuki N; Hiraoka N; Nibu KI; Yoshimoto S; Mori T
    BMC Cancer; 2019 Mar; 19(1):245. PubMed ID: 30885146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations].
    Hayashi N; Kitaoka M
    Nihon Rinsho; 2007 Nov; 65(11):2003-7. PubMed ID: 18018562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors: results of a meta-analysis.
    Stokowy T; Wojtaś B; Fujarewicz K; Jarząb B; Eszlinger M; Paschke R
    Horm Metab Res; 2014 Mar; 46(3):171-80. PubMed ID: 24446156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
    Paunovic I; Isic T; Havelka M; Tatic S; Cvejic D; Savin S
    APMIS; 2012 May; 120(5):368-79. PubMed ID: 22515291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.